You are here: Industry Insights > cipla

News List

Lilly signs licensing agreements with Cipla, Lupin and Sun Pharma for Baricitinib in India expresspharma
May 11, 2021
Eli Lilly and Company announced that it has issued royalty-free, non-exclusive voluntary licenses to established Indian pharmaceutical manufacturers of generic medicines, Cipla, Lupin and Sun Pharmaceutical Industries, who are collaborating with Lilly ...
Cipla signs licensing deal with Lilly to manufacture and commercialise baricitinib in India expresspharma
May 10, 2021
Baricitinib was issued a restricted emergency use approval by CDSCO to treat COVID-19.
Ramp up remdesivir manufacturing to full capacity: Govt to pharma firms expresspharma
April 09, 2021
Mansukh Mandaviya said seven manufacturers - Mylan, Hetero, Jubiliant Life Sciences, Cipla, Dr Reddy's, Zydus Cadila and Sun Pharma - have a monthly production capacity of 31.60 lakh vials.
Cipla board approves reappointment of Umang Vohra as MD & Global CEO for 5 years expresspharma
March 25, 2021
Cipla on Tuesday said its board has approved the re-appointment of Umang Vohra as the Managing Director and Global CEO of the company for a further period of five years.
Cipla Therapeutics and SIGA Technologies enter into strategic partnership expresspharma
March 24, 2021
The partnership is to support innovation and provide access to novel antibacterial drugs against biothreats.
Cipla takes deal route with Alvotech to enter Australian autoimmune biosimilars market: GlobalData expresspharma
March 22, 2021
Australia continues to focus on reducing healthcare expenditure and encouraging the use of biosimilars over their reference product.
Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX® (Sumatriptan Nasal Spray, 20 mg) prnasia
March 02, 2021
Cipla Limited today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray, 20 mg from the United States Food and Drug Administration (U.S. FDA).
Cipla Gulf expands partnership with Alvotech for commercialisation of biosimilars in Australia and New Zealand expresspharma
March 02, 2021
Cipla has announced that it’s subsidiary, Cipla Gulf is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand.
Cipla, Strides Pharma recall drugs in the US market expresspharma
January 11, 2021
Cipla has recalled packets of esomeprazole magnesium for delayed-release oral suspension while Strides Pharma has recalled Tacrolimus capsules.
Cipla launches rapid antigen detection test to diagnose COVID-19 expresspharma
December 16, 2020
Cipla announced its partnership with the Premier Medical Corporation for commercialisation of the rapid antigen test kits for COVID-19 in India. The company will commence supply from this week.

Previous page 1 2 3 4 5 6 7 8 Next page